CVS Health Corp. will pay $484 million to settle opioid-related claims by the state of Florida, the first time the pharmacy chain has agreed to payments to resolve a government lawsuit tied to opioid prescription abuse.
CVS was one of several defendants in a trial that was scheduled to begin in April. Drugmaker Teva Pharmaceutical Industries Ltd. also said Wednesday that it reached a settlement in which it will pay $177 million to Florida over 15 years and provide generic Narcan, or naloxone hydrochloride nasal spray, valued at $84 million over 10 years.
To Read the Full Story
This post first appeared on wsj.com
